EGA
LLY icon

Eagle Global Advisors’s Eli Lilly LLY Stock Holding History

Eagle Global Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-599
Closed -$466K – 243
2024
Q1 		$466K Buy
599
+124
+26% +$88.2K 0.03% 180
2023
Q4 		$277K Sell
475
-17
-3% -$9.92K 0.02% 203
2023
Q3 		$264K Sell
492
-10
-2% -$5.15K 0.02% 198
2023
Q2 		$235K Buy
+502
New +$211K 0.02% 207
2017
Q3 		– Sell
-3,012
Closed -$248K – 312
2017
Q2 		$248K Buy
+3,012
New +$246K 0.01% 329

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eagle Global Advisors's LLY Position: Q2 2024 in Review

Eagle Global Advisors sold out of Eli Lilly (LLY) in Q2 2024, closing a stake of 599 shares — an estimated $466K sold.

Eagle Global Advisors first reported a position in LLY in Q2 2017 and held it in 5 quarters. The position peaked at $466K in Q1 2024. 3,564 funds tracked by Wall St. Rank hold LLY as of Q2 2024.

  • Eagle Global Advisors reported no remaining Eli Lilly position as of Q2 2024 after selling out during the quarter.
  • Eagle Global Advisors sold 599 Eli Lilly shares in Q2 2024, an estimated $466K.
  • Eagle Global Advisors first reported a position in Eli Lilly in Q2 2017 and held it in 5 quarters.
  • Eagle Global Advisors's Eli Lilly position peaked at $466K in Q1 2024.
  • 3,564 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2024.

Based on Eagle Global Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.